CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.33
−3.16%Price chart
Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22
Key dataOct 22, 2026
Open$32.00
From 52W high−3.16%
Volume627331.00
Market cap$8.85B
P/E (TTM)84.2x
P/S (TTM)8.9x
Div yield—
Key dataOct 22, 2026
Open
$32.00
From 52W high
−3.16%
Volume
627331.00
Market cap
$8.85B
ValuationView details →
P/E (Fwd)
101.7x
EV/EBITDA
49.3x
P/E (TTM)
84.2x
RSI (14)
58.0
MomentumView details →
1D Return
−3.16%
YTD Return
+16.20%
Similar companies
Latest newsMore news →
Caris Life Sciences, Inc. announced the launch of a national commercial promoting its Caris Detect multi-cancer early detection test, featuring Jordan Spieth.3d agoCaris Life Sciences, Inc. announced that it will report its third-quarter 2026 financial results on November 4, 2026, and host a live webcast at 3:30 p.m.7d ago